drugset / Trial / NCT07388511
A Study of Elenestinib in Healthy Adult Female Participants
NaSequentialOpen-labelOther
Summary
The main objectives of this study are to determine the effect of elenestinib on the pharmacokinetic parameters (how the drug is absorbed, distributed, and processed by the body) of midazolam, and to determine the effect of elenestinib on the pharmacokinetic parameters of levonorgestrel/ethinyl estradiol, when given as a combined oral contraceptive. Healthy adult participants will receive midazolam and levonorgestrel/ethinyl estradiol with and without elenestinib and have blood samples taken.
Timeline
- Start
- 2026-02-05
- Primary completion
- 2026-04-02
- Completion
- 2026-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elenestinib | Small molecule | — | — |
| Subject | Levonorgestrel | Small molecule | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | ethinyl estradiol | Small molecule | — | — |
Indications
No indication recorded.